Understanding and Improving Lab-Grown Pancreatic Cells for Diabetes
Charting human islet maturation via combined soft nanoelectronics and single-cell spatial transcriptomics
This project aims to understand how lab-grown pancreatic cells develop and work, hoping to create better treatments for people with type 1 diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11113944 on NIH RePORTER |
What this research studies
People with type 1 diabetes struggle with managing their blood sugar because their bodies lose the cells that make insulin. While insulin injections help, they can be difficult and have side effects. Scientists are exploring transplanting lab-grown pancreatic cells, called SC-islets, to replace the lost cells. However, these SC-islets don't yet work as well as natural ones. This project uses advanced tools to map out how these SC-islets grow and interact in 3D, helping us understand why they aren't perfect. By learning more about their development, we hope to make them more effective for future treatments.
Who could benefit from this research
Good fit: This foundational research is ultimately for individuals living with type 1 diabetes who might benefit from future stem cell therapies.
Not a fit: Patients whose diabetes is not related to pancreatic islet dysfunction or who are not candidates for cell-based therapies may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to more effective and safer stem cell-based treatments for type 1 diabetes, reducing the need for daily insulin injections.
How similar studies have performed: This project uses novel combinations of technologies to address fundamental questions about stem cell islet maturation that are currently unknown.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Liu, Jia — Harvard University
- Study coordinator: Liu, Jia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.